What is a stock summary page? Click here for an overview.
Business Description
Augmedix Inc
NAICS : 923120
SIC : 7372
ISIN : US05105P1075
Description
Augmedix Inc is engaged in ambulatory/clinical/hospital segments of the U.S. patient care services market with products that address medical note documentation needs. The company's products cater to large and small healthcare organizations but can also be adopted by individual practitioners. The company products extract data from natural clinician-patient conversations and convert it in real time to medical notes, which are seamlessly transferred to the electronic health record (EHR). The company's revenues consist of service fees charged to its customers to subscribe to the company's remote medical documentation and clinical support products.
Financial Strength
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.12 | |||||
| Equity-to-Asset | 0.2 | |||||
| Debt-to-Equity | 2.41 | |||||
| Debt-to-EBITDA | -1.28 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | -2.55 | |||||
| Beneish M-Score | -2.35 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 18.5 | |||||
| 3-Year EBITDA Growth Rate | 10.3 | |||||
| 3-Year EPS without NRI Growth Rate | 9 | |||||
| 3-Year FCF Growth Rate | 9 | |||||
| 3-Year Book Growth Rate | 60.5 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 12.83 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 72.06 | |||||
| 9-Day RSI | 71.04 | |||||
| 14-Day RSI | 74.07 | |||||
| 3-1 Month Momentum % | 136.28 | |||||
| 6-1 Month Momentum % | -42.29 | |||||
| 12-1 Month Momentum % | -55.89 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.66 | |||||
| Quick Ratio | 1.66 | |||||
| Cash Ratio | 1.18 | |||||
| Days Sales Outstanding | 66.07 | |||||
| Days Payable | 17.13 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -21.9 | |||||
| Shareholder Yield % | -4.35 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 48.22 | |||||
| Operating Margin % | -46.29 | |||||
| Net Margin % | -46.23 | |||||
| FCF Margin % | -34.65 | |||||
| ROE % | -211.81 | |||||
| ROA % | -45.06 | |||||
| ROIC % | -82.19 | |||||
| 3-Year ROIIC % | -37.2 | |||||
| ROC (Joel Greenblatt) % | -281.2 | |||||
| ROCE % | -72.48 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 2.29 | |||||
| PB Ratio | 11.03 | |||||
| Price-to-Tangible-Book | 11.19 | |||||
| EV-to-EBIT | -5.33 | |||||
| EV-to-EBITDA | -5.71 | |||||
| EV-to-Revenue | 2.19 | |||||
| EV-to-Forward-Revenue | 1.74 | |||||
| EV-to-FCF | -6.33 | |||||
| Price-to-GF-Value | 0.66 | |||||
| Earnings Yield (Greenblatt) % | -18.76 | |||||
| FCF Yield % | -15.39 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:AUGX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Augmedix Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 51.582 | ||
| EPS (TTM) ($) | -0.472 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | 0.3 | ||
| 3-Year Sortino Ratio | 0.66 | ||
| Volatility % | 186.01 | ||
| 14-Day RSI | 74.07 | ||
| 14-Day ATR ($) | 0.014761 | ||
| 20-Day SMA ($) | 2.3315 | ||
| 12-1 Month Momentum % | -55.89 | ||
| 52-Week Range ($) | 0.73 - 6.25 | ||
| Shares Outstanding (Mil) | 49.43 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Augmedix Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Augmedix Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Augmedix Inc Frequently Asked Questions
What is Augmedix Inc(AUGX)'s stock price today?
The current price of AUGX is $2.35. The 52 week high of AUGX is $6.25 and 52 week low is $0.73.
When is next earnings date of Augmedix Inc(AUGX)?
The next earnings date of Augmedix Inc(AUGX) is 2025-05-13 Est..
Does Augmedix Inc(AUGX) pay dividends? If so, how much?
Augmedix Inc(AUGX) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers